The interaction effect of O₃ with age. حسب John Brandt (6880463)

الموضوعات:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... حسب Naoya Itoh (6029276)

الموضوعات:

S1 Dataset - حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Pop-up for oral 3GC prescription. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Species richness decreases significantly with increasing percent disturbance. حسب Catherine L. Cardelús (6429320)

Clustering effect. حسب Zhongbo Peng (16884034)

الموضوعات:

Descriptive statistics for total cumulative study treatment costs. حسب Phoebe K. McCutchan (12042038)

الموضوعات:

Comparable characteristics between the two groups after PSM. حسب Long Xue (10926423)

الموضوعات: